Rumors say Glock will end sales of most pistols Nov. 30 after California bans easily convertible handguns. Glock hasn’t ...

An exchange-traded fund that equally weights stocks in the S&P 500 was posting a solid gain in early afternoon trading Friday, beating the U.S. large-cap equities benchmark amid a broad rally. The ...

Fintel reports that on September 29, 2025, Morgan Stanley maintained coverage of Fifth Third Bancorp - Preferred Stock (NasdaqGS:FITBO) with a Equal-Weight recommendation. Analyst Price Forecast ...

Fintel reports that on September 29, 2025, Stephens & Co. reiterated coverage of First Merchants Corporation - Preferred Stock (NasdaqGS:FRMEP) with a Equal-Weight recommendation. Analyst Price ...

To show, or not to show? That is the question all emerging brands have to weigh, while trying to balance exposure and the bottom line. Since 2022, Avavav’s Beate Skonare Karlsson has used her digital ...

At Rentrayage, Erin Beatty has been fine-tuning her creative approach to fall more in tune with both retail and production demands. “We’re in a really difficult economy and the stores are just too ...

A Coral Springs man was arraigned Wednesday on charges relating to a plot to bomb the New York Stock Exchange to force a "reboot" or "reset" of the U.S. government, according to prosecutors. The U.S.

EL PASO COUNTY, Colo. (KRDO) - A former Little League treasurer from Colorado Springs was sentenced to jail time, probation, and community service on Tuesday, Sept. 23. Michele Gorr pleaded guilty ...

Eli Lilly's shares have increased by about 10% over the past month. Clinical progress in the past few weeks has helped solidify its lead in the weight loss market. The company's prospects remain ...

Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. The test estimates an individual's calories to satiation ...

Weight-loss with Lilly's GLP-1 pill plateaus for most patients Orforglipron improves cardiovascular risk factors, reduces inflammation marker by 47.7% High-dose orforglipron group sees 10.3% dropout ...

FDA's new voucher could shorten drug review to 1-2 months Lilly's orforglipron targets high-burden chronic condition Analysts predict price erosion due to new market entrants Sept 16 (Reuters) - Eli ...